The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital is now accepting proposals for the 2020 Healey Scholars Program, which provides funding for young investigators researching new treatments for people living with ALS. This two-year program is designed to engage clinician-scientists and post-doctoral fellows to gain training and experience in therapy development for ALS at their home institution with the optional industry experience in year two. All Healey Scholars will be part of the broader Healey & AMG Center’s global community. By engaging motivated and creative individuals with a passion for bringing treatments to people living with ALS, we will expand the community of experts and expedite therapy development. We believe strongly in identifying, supporting, and mentoring the next generation of researchers continuing this tradition through our Healey Scholars Program.

Healey Scholars will be an integral member of the Healey & AMG Center for ALS at Mass General and will benefit from mentorship by world renowned scientists and clinicians. While working closely with their mentors at their home institution, the Scholars will also attend Healey Center meetings and learn first-hand approaches to therapy development. Importantly, Scholars will have the opportunity to engage with people living with ALS. In addition, successful candidates interested in understanding the drug development process from an industry perspective, will benefit from an optional six-month internship in industry during the second year of their scholarship.